Cetera Investment Advisers Sells 20,716 Shares of Cronos Group Inc. (NASDAQ:CRON)

Cetera Investment Advisers cut its position in Cronos Group Inc. (NASDAQ:CRON) by 47.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 23,392 shares of the company’s stock after selling 20,716 shares during the quarter. Cetera Investment Advisers’ holdings in Cronos Group were worth $47,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Dimensional Fund Advisors LP increased its stake in shares of Cronos Group by 5.1% in the fourth quarter. Dimensional Fund Advisors LP now owns 2,753,055 shares of the company’s stock valued at $5,561,000 after buying an additional 132,536 shares during the period. Cannell Capital LLC acquired a new stake in shares of Cronos Group in the fourth quarter valued at about $3,323,000. Geode Capital Management LLC increased its stake in shares of Cronos Group by 6.4% in the fourth quarter. Geode Capital Management LLC now owns 546,700 shares of the company’s stock valued at $1,104,000 after buying an additional 33,121 shares during the period. Kerrisdale Advisers LLC increased its stake in shares of Cronos Group by 2.3% in the fourth quarter. Kerrisdale Advisers LLC now owns 468,786 shares of the company’s stock valued at $947,000 after buying an additional 10,539 shares during the period. Finally, Janney Montgomery Scott LLC increased its stake in shares of Cronos Group by 72.2% in the fourth quarter. Janney Montgomery Scott LLC now owns 380,575 shares of the company’s stock valued at $769,000 after buying an additional 159,575 shares during the period. 8.71% of the stock is currently owned by institutional investors.

Cronos Group Price Performance

NASDAQ CRON opened at $1.92 on Tuesday. The business has a 50 day simple moving average of $1.87 and a 200 day simple moving average of $1.93. Cronos Group Inc. has a one year low of $1.60 and a one year high of $2.61. The stock has a market capitalization of $740.01 million, a P/E ratio of -14.77, a P/E/G ratio of 1.74 and a beta of 1.06.

Cronos Group (NASDAQ:CRON) last announced its quarterly earnings data on Thursday, May 8th. The company reported $0.02 EPS for the quarter, beating analysts’ consensus estimates of $0.01 by $0.01. Cronos Group had a negative return on equity of 2.56% and a negative net margin of 42.65%. The firm had revenue of $33.62 million during the quarter, compared to analysts’ expectations of $45.44 million. Equities analysts expect that Cronos Group Inc. will post -0.03 earnings per share for the current year.

Cronos Group Company Profile

Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.